NISA INVESTMENT ADVISORS, LLC
Position in CATX — Perspective Therapeutics, Inc.
CIK 937615
ST. LOUIS, MO
Position in CATX
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$52,925
+$52,540 QoQ
Shares Held
12,692
+8965.7% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CATX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026NISA INVESTMENT ADVISORS, LLC holds $149,121,514 across 69 Medical Devices names. CATX ranks #24 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
485,052 | $49,800,288 | |
| 2 | SYK |
Stryker Corp
|
98,531 | $32,376,300 | |
| 3 | EW |
Edwards Lifesciences Corp
|
224,857 | $18,006,548 | |
| 4 | BSX |
Boston Scientific Corp
|
251,661 | $15,791,727 | |
| 5 | MDT |
Medtronic plc
|
171,647 | $14,873,212 | |
| 6 | DXCM |
Dexcom Inc
|
51,235 | $3,217,558 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
43,407 | $3,089,710 | |
| 8 | ZBH |
Zimmer Biomet Holdings, Inc.
|
32,913 | $2,975,993 |
All Filings in CATX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $52,925 | 12,692 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $385 | 140 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $16,254 | 4,739 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $16,302 | 4,739 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $11,069 | 5,197 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $2,552 | 800 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $12,735 | 954 | Shares | Sole | 2024-10-24 | |
| No filing history on record for this holder in this stock. | ||||||